Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-11-23FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA has approved a supplemental application for escitalopram oxalate from Rising Pharma Holdings, Inc.
-
FDA approval · 2022-11-21FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Cipla USA Inc. to market generic citalopram. This action confirms the availability of a gene…
-
FDA approval · 2022-11-21FDA Approved: VENLAFAXINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for venlafaxine submitted by Ascend Laboratories, LLC.
-
FDA approval · 2022-11-15FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith's fluoxetine hydrochloride as an original generic application, allowing the generic product to be marketed wit…
-
FDA approval · 2022-11-09FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride by Teva Pharmaceuticals USA, Inc., authorizing changes to the produc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-11-09FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA071524, approving a generi…
-
FDA approval · 2022-11-09FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2022-11-09FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' original application for fluoxetine hydrochloride, a generic version of fluoxetine.
-
FDA approval · 2022-10-27FDA Approved: ARIPIPRAZOLE — Original Application (Advagen Pharma Ltd)
FDA approves Advagen Pharma Ltd's original application for a generic aripiprazole product.
-
FDA approval · 2022-10-25FDA Approved: ARIPIPRAZOLE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original application for a generic aripiprazole product. Aripiprazole is used to treat schizophrenia, b…
-
FDA approval · 2022-10-18FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved the supplemental application for trazodone hydrochloride from Zydus Lifesciences Limited. This confirms regulatory approval of …
-
FDA approval · 2022-10-05FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for citalopram submitted by Torrent Pharmaceuticals Limited.
-
FDA approval · 2022-09-20FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for ARIPIPRAZOLE by Dr. Reddy's Laboratories Inc. under the ANDA, authorizing a modification to the …
-
FDA approval · 2022-09-15FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
FDA granted a supplemental approval to Aurolife Pharma LLC for a generic form of mirtazapine, authorizing continued supply of the antidepres…
-
FDA approval · 2022-09-15FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for mirtazapine from Sun Pharmaceutical Industries, Inc. (ANDA 076541). The action supports cont…
-
FDA approval · 2022-09-15FDA Approved: MIRTAZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic version of mirtazapine by Mylan Pharmaceuticals, confirming continued approval for maj…
-
FDA approval · 2022-09-02FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for bupropion hydrochloride from Epic Pharma LLC, indicating approval of a generic formulation.
-
FDA approval · 2022-08-31FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for citalopram hydrobromide by Aurobindo Pharma Limited, representing a generic version of citalopra…
-
FDA approval · 2022-08-30FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride as a generic, confirming approval under the ANDA p…
-
FDA approval · 2022-08-30FDA Approved: VENLAFAXINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application (ANDA) for venlafaxine from Zydus Lifesciences Limited, enabling generic access to the antidepressant.
-
FDA approval · 2022-08-24FDA Approved: QUETIAPINE — Original Application (Solco Healthcare US, LLC)
FDA approves Solco Healthcare's original application for a generic quetiapine product (quetiapine fumarate tablets), enabling a generic vers…
-
FDA approval · 2022-08-18FDA Approved: AUVELITY — Original Application (Axsome Therapeutics, Inc.)
AUVELITY is FDA-approved as a fixed-dose combination of dextromethorphan hydrobromide and bupropion hydrochloride for the treatment of adult…
-
FDA approval · 2022-08-15FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC.
-
FDA approval · 2022-08-15FDA Approved: QUETIAPINE — Original Application (BluePoint Laboratories)
FDA approved a generic version of quetiapine from BluePoint Laboratories under an Original Application (ANDA 215478).
-
FDA approval · 2022-08-09FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Venlafaxine Hydrochloride (extended-release) submitted by Chartwell RX, LLC.